Cited by 29Neurological Disorders and TreatmentsAcute Ischemic Stroke ManagementNeurological Disease Mechanisms and Treatments

Phycocyanobilin reduces brain injury after endothelin-1- induced focal cerebral ischaemia

Pavón‐Fuentes, Nancy, Marín‐Prida, Javier, Llópiz‐Arzuaga, Alexey, Falcón‐Cama, Viviana, Campos‐Mojena, Rosario, Cervantes‐Llanos, Majel, Piniella‐Matamoros, Beatriz, Pentón‐Arias, Eduardo +1 more·2020·Clinical and Experimental Pharmacology and Physiology

Abstract

Pharmacological therapies for interrupting biochemical events of the ischaemic cascade and protecting against stroke in humans are as yet unavailable. Up to now, the neuroprotective activity in cerebral ischaemia of phycocyanobilin (PCB), a tetrapyrrolic natural antioxidant, has not been fully examined. Here, we evaluated if PCB protects PC12 neuronal cells against oxygen and glucose deprivation plus reperfusion, and its protective effects in a rat model of endothelin-1-induced focal brain ischaemia. PCB was purified from the cyanobacteria Spirulina platensis and characterized by spectrophotometric, liquid and gas chromatography and mass spectrometry techniques. In Wistar rats, PCB at 50, 100 and 200 μg/kg or phosphate-buffered saline (vehicle) was administered intraperitoneally at equal subdoses in a therapeutic schedule (30 minutes, 1, 3 and 6 hours after the surgery). Brain expression of myelin basic protein (MBP) and the enzyme CNPase was determined by immunoelectron microscopy. PCB was obtained with high purity (>95%) and the absence of solvent contaminants and was able to ameliorate PC12 cell ischaemic injury. PCB treatment significantly decreased brain infarct volume, limited the exploratory behaviour impairment and preserved viable cortical neurons in ischaemic rats in a dose-dependent manner, compared to the vehicle group. Furthermore, PCB at high doses restored the MBP and CNPase expression levels in ischaemic rats. An improved PCB purification method from its natural source is reported, obtaining PCB that is suitable for pharmacological trials showing neuroprotective effects against experimental ischaemic stroke. Therefore, PCB could be a therapeutic pharmacological alternative for ischaemic stroke patients.

Integrity signals

Registry

Crossref · 10.1111/1440-1681.13214

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PCB treatment significantly reduced brain infarct volume, limited exploratory behavior impairment, and preserved viable cortical neurons in ischemic rats in a dose-dependent manner with respect to the vehicle group.

    “PCB treatment significantly reduced brain infarct volume, limited exploratory behavior impairment, and preserved viable cortical neurons in ischemic rats in a dose-dependent manner with respect to the vehicle group.”

    From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [65]

  • PCB at high doses restored the expression levels of myelin basic protein and the enzyme CNPase in ischemic rats.

    “Furthermore, PCB at high doses restored the expression levels of myelin basic protein and the enzyme CNPase in ischemic rats [65].”

    From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [65]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pavón‐Fuentes, N., Marín‐Prida, J., Llópiz‐Arzuaga, A., Falcón‐Cama, V., Campos‐Mojena, R., Cervantes‐Llanos, M., Piniella‐Matamoros, B., Pentón‐Arias, E., & Pentón‐Rol, G.
Affiliations
  • International Centre for Neurological Restoration (CIREN) Havana Cuba
  • University of Havana (CU)
  • Centre for Genetic Engineering and Biotechnology (CIGB) Havana Cuba
  • Centro de Ingeniería Genética y Biotecnología (CU)
Corresponding author
Pentón‐Rol, Giselle
Venue
Clinical and Experimental Pharmacology and Physiology
Publisher
Wiley
Published
2019-12-06
Volume
47
Issue
3
Pages
383-392
ISSN
  • 0305-1870 (ISSN-L)
  • 1440-1681
OpenAlex
W2988204461
Cited by
29
References
53
Citations by year
2026: 5 · 2025: 3 · 2024: 7 · 2022: 7 · 2021: 6 · 2020: 1
FWCI
1.54
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical and Experimental Pharmacology and Physiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
phycocyanobilin, neuroprotection, cerebral ischemia, ischemic stroke, endothelin-1, oxygen-glucose deprivation, PC12 cells, myelin basic protein, CNPase, infarct size, exploratory behavior, cyanobacteria, Spirulina platensis
MeSH terms
Animals, Brain Injuries, Brain Ischemia, Male, Phycocyanin, PC12 Cells, Rats, Wistar, Endothelin-1, Rats, Phycobilins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review